In the last 19 years, only 0.92 % trading sessions saw intraday declines higher than 5 % .
Pfizer Share Price
Loading...
Pfizer Share Price
Advertisment
Pfizer share price insights
View All
Company has spent less than 1% of its operating revenues towards interest expenses and 15.86% towards employee cost in the year ending Mar 31, 2024. (Source: Standalone Financials)
Stock gave a 3 year return of 4.64% as compared to Nifty Midcap 100 which gave a return of 112.53%. (as of last trading session)
Stock generated 4.64% return as compared to Nifty Pharma which gave investors 64.02% return over 3 year time period. (as of last trading session)
Pfizer Ltd. share price moved up by 0.58% from its previous close of Rs 5,956.65. Pfizer Ltd. stock last traded price is 5,990.95
Share Price Value Today/Current/Last 5,990.95 Previous Day 5,956.65
Key Metrics
PE Ratio (x) | 45.07 | ||||||||||
EPS - TTM (₹) | 133.01 | ||||||||||
MCap (₹ Cr.) | 27,425.77 | ||||||||||
Sectoral MCap Rank | 21 | ||||||||||
PB Ratio (x) | 30.24 | ||||||||||
Div Yield (%) | 0.58 | ||||||||||
Face Value (₹) | 10.00 | ||||||||||
Beta Beta
| -0.21 | ||||||||||
VWAP (₹) | 6,001.19 | ||||||||||
52W H/L (₹) |
Pfizer Share Price Returns
| 1 Day | 0.56% |
| 1 Week | 2.3% |
| 1 Month | 7.32% |
| 3 Months | 30.87% |
| 1 Year | 55.99% |
| 3 Years | 4.53% |
| 5 Years | 104.76% |
Pfizer News & Analysis
News
FDA approves updated COVID-19 vaccines, shots should be available in days
News
HAL among 19 stocks to trade ex-dividend on Wednesday. Last day to buy for eligibility
News
AstraZeneca gets $107 mln Pfizer verdict overturned in US cancer drug patent fightShareholder Meeting / Postal Ballot-Scrutinizer''s Report
Announcements
Pfizer Share Analysis
Unlock Stock Score, Analyst' Ratings & Recommendations
- View Stock Score on a 10-point scale
- See ratings on Earning, Fundamentals, Valuation, Risk & Price
- Check stock performance
JOIN ET PRIME
Pfizer Share Recommendations
Recent Recos
BUY
Current
Mean Recos by 3 Analysts
Strong
SellSellHoldBuyStrong
Buy
SellSellHoldBuyStrong
Buy
That's all for Pfizer recommendations. Check out other stock recos.
Analyst Trends
| Ratings | Current | 1 Week Ago | 1 Month Ago | 3 Months Ago |
|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 2 |
| Buy | - | - | - | - |
| Hold | 2 | 2 | 2 | 1 |
| Sell | - | - | - | - |
| Strong Sell | - | - | - | - |
| # Analysts | 3 | 3 | 3 | 3 |
View all
Stock Recommendations
Pfizer Financials
Income (P&L)
Balance Sheet
Cash Flow
Ratios
Insights
Employee & Interest Expense
Company has spent less than 1% of its operating revenues towards interest expenses and 15.86% towards employee cost in the year ending Mar 31, 2024. (Source: Standalone Financials)
No reported Profit & Loss Statement are available.
No reported Balance Sheet are available.
Insights
Cash from Operations vs PAT
Operating cash flow of Rs 256.84 cr is 0.47 times compared to the reported net profit of Rs 551.33 cr. (Source: Standalone Financials)
No reported Cash Flow Statement are available.
No reported Financial Ratios are available.
Pfizer Share Price Forecast
PRICE
REVENUE
EARNINGS
Get multiple analysts’ prediction on Pfizer
- High, low, medium predictions for Price
- Upcoming predictions for Revenue
- Details about company earnings
START FREE TRIALGet multiple analysts’ prediction on Pfizer
- High, low, medium predictions for Price
- Upcoming predictions for Revenue
- Details about company earnings
START FREE TRIALGet multiple analysts’ prediction on Pfizer
- High, low, medium predictions for Price
- Upcoming predictions for Revenue
- Details about company earnings
START FREE TRIAL
Pfizer Peer Comparison
Pfizer Stock Performance
Ratio Performance
Insights
Stock Returns vs Nifty Midcap 100
Stock gave a 3 year return of 4.64% as compared to Nifty Midcap 100 which gave a return of 112.53%. (as of last trading session)Stock Returns vs Nifty Pharma
Stock generated 4.64% return as compared to Nifty Pharma which gave investors 64.02% return over 3 year time period. (as of last trading session)
Choose from Peers
Choose from Stocks
- 1D
- 1W
- 1M
- 3M
- 6M
- 1Y
- 5Y
Loading...Insights
Stock Returns vs Nifty Midcap 100
Stock gave a 3 year return of 4.64% as compared to Nifty Midcap 100 which gave a return of 112.53%. (as of last trading session)Stock Returns vs Nifty Pharma
Stock generated 4.64% return as compared to Nifty Pharma which gave investors 64.02% return over 3 year time period. (as of last trading session)
See All Parameters
MF Ownership
578.17
Amount Invested (in Cr.)
0.96%
% of AUM
0.00
% Change (MoM basis)
Nippon India Multi Cap Direct-G
Equity: Multi Cap
205.04
Amount Invested (in Cr.)
0.55%
% of AUM
0.00
% Change (MoM basis)
179.84
Amount Invested (in Cr.)
2.21%
% of AUM
0.00
% Change (MoM basis)
MF Ownership as on 31 July 2024
Pfizer F&O Quote
Futures
Options
Corporate Actions
Pfizer Board Meeting/AGM
Pfizer Dividends
- Others
Meeting Date Announced on Purpose Details Jul 29, 2024 Jul 22, 2024 Board Meeting Quarterly Results May 17, 2024 May 06, 2024 Board Meeting Audited Results & Final Dividend Apr 02, 2024 Feb 29, 2024 POM - Feb 09, 2024 Jan 31, 2024 Board Meeting Quarterly Results Jan 09, 2024 Dec 07, 2023 POM - Type Dividend Dividend per Share Ex-Dividend Date Announced on Final 350% 35.0 Aug 21, 2024 May 17, 2024 Special 50% 5.0 Aug 11, 2023 May 16, 2023 Final 350% 35.0 Aug 11, 2023 May 15, 2023 Special 300% 30.0 Sep 19, 2022 Sep 06, 2022 Final 350% 35.0 Aug 18, 2022 May 20, 2022 All Types Ex-Date Record Date Announced on Details Bonus Jun 12, 2000 Jun 28, 2000 May 25, 2000 Bonus Ratio: 1 share(s) for every 1 shares held Bonus - - Jul 25, 1977 Bonus Ratio: 4 share(s) for every 5 shares held Bonus - - Jul 25, 1972 Bonus Ratio: 2 share(s) for every 5 shares held Bonus - - Bonus Ratio: 1 share(s) for every 2 shares held
About Pfizer
Pfizer Ltd., incorporated in the year 1950, is a Large Cap company (having a market cap of Rs 27,250.32 Crore) operating in Pharmaceuticals sector. Pfizer Ltd. key Products/Revenue Segments include Pharmaceuticals, Sale of services, Scrap for the year ending 31-Mar-2024. Show More
Executives
Auditors
- PS
Pradip Shah
Chairman & Ind.DirectorMNMeenakshi Nevatia
Managing DirectorAAAmit Agarwal
Executive Director & CFOPRP Rengan
Executive Director - OperationsShow More - BSR & Co. LLPWalker Chandiok & Co. LLP
Industry
Key Indices Listed on
BSE 500, BSE 250 SmallCap Index, BSE SmallCap, + 6 more
Address
The Capital,1802 / 1901, 18th Floor,Mumbai, Maharashtra - 400051
More Details
Trending in Markets
DATA SOURCES: TickerPlant (for live BSE/NSE quotes service) and Dion Global Solutions Ltd. (for corporate data, historical price & volume, F&O data). Sensex & BSE Quotes and Nifty & NSE Quotes are real-time and licensed from BSE and NSE respectively. All timestamps are reflected in IST (Indian Standard Time).
DISCLAIMER: Any and all content on this website including tools/analysis is provided to you only for convenience and on an “as-is, as- available” basis without representation and warranties of any kind. The content and any output of such tools/analysis is for informational purposes only and should not be relied upon or construed as an investment advice or guarantee for any specific performance/returns advice or considered as recommendation for the purchase or sale of any security or investment. You are advised to exercise caution, discretion and independent judgment with regards to the same and seek advice from professionals and certified experts before taking any decisions.
By using this site, you agree to the Terms of Service and Privacy Policy.
